Literature DB >> 5942016

Infectious mononucleosis with central nervous system involvement.

R N Fine, R A Faciana, W H Bucher.   

Abstract

Mesh:

Year:  1966        PMID: 5942016      PMCID: PMC1516212     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


× No keyword cloud information.
  13 in total

1.  Fatal encephalopathy in glandular fever.

Authors:  J D BERGIN
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

2.  Mononucleosis, Guillain-Barré syndrome and paralysis of the posterior crico-arytenoid muscle.

Authors: 
Journal:  Acta Otolaryngol       Date:  1956 Jan-Feb       Impact factor: 1.494

3.  Retrobulbar neuritis; a complication of infectious mononucleosis.

Authors:  F R SHECHTER; E I LIPSIUS; H N RASANSKY
Journal:  AMA Am J Dis Child       Date:  1955-01

4.  The Guillain-Barre syndrome as a manifestation of infectious mononucleosis; report of a case.

Authors:  J Q DURFEY; J E ALLEN
Journal:  N Engl J Med       Date:  1956-02-09       Impact factor: 91.245

5.  Infectious mononucleosis encephalitis.

Authors:  F C WALSH; C M POSER; S CARTER
Journal:  Pediatrics       Date:  1954-06       Impact factor: 7.124

6.  Neurologic manifestations of infectious mononucleosis in childhood.

Authors:  F E KARPINSKI
Journal:  Pediatrics       Date:  1952-09       Impact factor: 7.124

7.  Infectious mononucleosis and Guillain-Barré syndrome; report of three cases.

Authors:  M RAFTERY; E E SCHUMACHER; G O GRAIN; E L QUINN
Journal:  AMA Arch Intern Med       Date:  1954-02

8.  Encephalitis probably due to infectious mononucleosis. Report of four cases.

Authors:  W W NICHOLS; B ATHREYA
Journal:  Am J Dis Child       Date:  1962-01

9.  Severe optic neuritis in infectious mononucleosis; report of a case.

Authors:  T W BONYNGE; K O VON HAGEN
Journal:  J Am Med Assoc       Date:  1952-03-15

10.  Involvement of the nervous system in infectious mononucleosis.

Authors:  T C BERNSTEIN; H G WOLFF
Journal:  Ann Intern Med       Date:  1950-11       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.